Trillium Therapeutics Mergers and Acquisitions Summary

Life ScienceCompany

Trillium Therapeutics has acquired 1 company.

Trillium Therapeutics’ largest acquisition to date was in 2016, when it acquired Fluorinov Pharma for $34M. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to Trillium Therapeutics’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Trillium Therapeutics

Trillium Therapeutics Inc.

2488 Dunwin Drive,
Toronto, Ontario L5L 1J9
(416) 595-0627

Trillium Therapeutics is an immuno-oncology company developing innovative therapies for the treatment of cancer. Company lead program SIRPαFc is an antibody-like fusion protein that blocks the activity of CD47, a molecule that allows tumor cells to escape destruction by the immune system. Trillium Therapeutics was founded in 2004 and is based in Mississauga, Canada.

M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (0.0/yr) # 1 - - - - - 1
vol $34M $34M
Sell (0.0/yr) # - - - - - - 0

Most Recent M&A

Company Date Value Type
Fluorinov Pharma Inc. 2016-01-27 34M CAD Add-on Acquisition
Toronto, Ontario ·
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 34M (100%) - -
Total 1 $34M - -

By Geo

State/Country Buy Value Sell Value
Canada 1 34M - -
  Ontario 1 34M - -
Total 1 $34M - -

Deal Values

buy # Total
< $100M 1 $34M
Largest Fluorinov Pharma Inc.
$34M (2016-01-27)

 Subscribe to unlock this and 179,815
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.3K Private Equity Firms
  • 170K M&A Transactions
  • 175K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 63K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.